The agreement refinances an existing senior secured term loan facility. Along with the $60 million, the company will be able to draw down up to an additional $10 million.
Money from the initial investment will be used to retire Centinel Spine’s existing credit facility, fees and provide working capital.
Centinel Spine develops prodisc implants for total disc replacements.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
